Major Adverse Events of Cardiac Catheterization in Pediatric Cardiomyopathy: Insights From the IMPACT Registry

Read full text Summarise with VIRAT
Authors: Khalifah A Aldawsari, Kevin Kennedy, Alejandro Jesus. Martinez Herrada
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Despite the role of cardiac catheterization for hemodynamic assessment and endomyocardial biopsy in children with cardiomyopathy, data on procedure-related major adverse events (MAE) in this population are lacking. We aim to describe the rate of MAE in children with cardiomyopathy undergoing cardiac catheterization. Our secondary objective is to compare the rate of MAE among patient subsets within this population. METHODS: We included patients with cardiomyopathy from the National Cardiovascular Data Registry IMPACT (Improving Pediatric and Adult Congenital Treatment) who were 18 years old or younger and underwent cardiac catheterization between April 2016 and December 2024. Data collected included demographic, preprocedural, procedural, and outcome-related variables. We performed univariate and multivariate analyses to identify variables independently associated with MAE. RESULTS: A total of 4932 procedures were evaluated, with a median age of 10 years. Dilated cardiomyopathy was the most prevalent cardiomyopathy in 53.4%. The rate of MAE was 3.17%. The most common MAE was arrhythmia, representing 42.3% of all MAE. The multivariate analysis also revealed that age

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Congenital Heart Disease Studies Cardiac Arrhythmias and Treatments

Publication details

Journal / source
Journal of the American Heart Association
Volume
15
Issue
7
Pages
e047780–e047780
Publication date
25 March 2026
Language
EN